Skip to content

Cushman & Wakefield CWK Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Jones Lang LaSalle logo
Jones Lang LaSalleJLL
CoStar Group logo
CoStar GroupCSGP
Highwoods Properties logo
Highwoods PropertiesHIW
Healthcare Realty Trust logo
Healthcare Realty TrustHR
Cintas logo
CintasCTAS
W.P. Carey Inc. logo
W.P. Carey Inc.WPC

Other financials

Income statement

See full
Revenue$2.5B+11.0%
Gross profit$420.7M+9.5%
Operating income$58.7M+29.6%
Net income-$12.6M-763%
EPS (diluted)-$0.05-600%

Balance sheet

See full
Cash & equivalents$619.5M-3.2%
Total debt$3.2B-4.5%
Total equity$2.0B+9.9%
Total assets$7.6B+3.2%

Cash flow

See full
Operating cash flow-$243.5M-50.3%
CapEx$12.2M+165%
Free cash flow-$255.7M-53.5%

Valuation

See full
Market cap$3B+21.1%
Enterprise value$5.53B+7.3%
P/E30.6×
P/S0.3×0.0×

Profitability

See full
Gross margin18.2%-0.2pp
Operating margin4.4%+0.6pp
Net margin2.2%
FCF margin1.9%+0.5pp

Returns & leverage

See full
Return on equity12.2%
Debt / equity1.6×-0.2×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Cushman & Wakefield in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Cushman & Wakefield ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cushman & Wakefield 's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cushman & Wakefield 's common stock, shares authorized (in shares)?
Cushman & Wakefield (CWK) reported common stock, shares authorized (in shares) of $800M in Q1 2026.
How has Cushman & Wakefield 's common stock, shares authorized (in shares) changed year-over-year?
Cushman & Wakefield 's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $800M to $800M.
What is the long-term trend for Cushman & Wakefield 's common stock, shares authorized (in shares)?
Over 4 years (2021 to 2025), Cushman & Wakefield 's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $800M to $800M.